ES548901A0 - Procedimiento para la preparacion de derivados de esfingosina - Google Patents

Procedimiento para la preparacion de derivados de esfingosina

Info

Publication number
ES548901A0
ES548901A0 ES548901A ES548901A ES548901A0 ES 548901 A0 ES548901 A0 ES 548901A0 ES 548901 A ES548901 A ES 548901A ES 548901 A ES548901 A ES 548901A ES 548901 A0 ES548901 A0 ES 548901A0
Authority
ES
Spain
Prior art keywords
procedure
preparation
sphingosine derivatives
sphingosine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES548901A
Other languages
English (en)
Other versions
ES8606373A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ICN Switzerland AG
Original Assignee
Solco Basel AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH6493/83A external-priority patent/CH679209A5/de
Application filed by Solco Basel AG filed Critical Solco Basel AG
Publication of ES8606373A1 publication Critical patent/ES8606373A1/es
Publication of ES548901A0 publication Critical patent/ES548901A0/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02Acyclic radicals, not substituted by cyclic structures
    • C07H15/04Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES548901A 1983-12-05 1985-11-02 Procedimiento para la preparacion de derivados de esfingosina Expired ES8606373A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH6493/83A CH679209A5 (en) 1983-12-05 1983-12-05 New neutral glyco-sphingolipid derivs.
CH467184 1984-09-28

Publications (2)

Publication Number Publication Date
ES8606373A1 ES8606373A1 (es) 1986-04-16
ES548901A0 true ES548901A0 (es) 1986-04-16

Family

ID=25696036

Family Applications (2)

Application Number Title Priority Date Filing Date
ES538231A Expired ES8604986A1 (es) 1983-12-05 1984-12-04 Procedimiento para la preparacion de derivado de esfingosina.
ES548901A Expired ES8606373A1 (es) 1983-12-05 1985-11-02 Procedimiento para la preparacion de derivados de esfingosina

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES538231A Expired ES8604986A1 (es) 1983-12-05 1984-12-04 Procedimiento para la preparacion de derivado de esfingosina.

Country Status (11)

Country Link
US (1) US4952683A (es)
EP (1) EP0146810A3 (es)
AU (1) AU570087B2 (es)
CA (1) CA1259610A (es)
DK (1) DK573384A (es)
ES (2) ES8604986A1 (es)
FI (1) FI844775L (es)
HU (1) HU195516B (es)
NO (1) NO844815L (es)
PL (1) PL143901B1 (es)
YU (2) YU202784A (es)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1199116B (it) * 1984-07-03 1988-12-30 Fidia Farmaceutici Derivati di gangliosidi
DK17885D0 (da) * 1985-01-14 1985-01-14 Karlsson Karl Anders Antiviralt middel
EP0212400B1 (de) * 1985-08-13 1992-01-02 Solco Basel AG Neues Verfahren zur Herstellung von Sphingosinderivaten
US4769362A (en) * 1985-10-01 1988-09-06 Trustees Of Boston University Increased vascular perfusion following administration of lipids
JPH07116209B2 (ja) * 1986-04-11 1995-12-13 メクト株式会社 シアロシルセラミド類及びその製造方法
EP0255717A3 (en) * 1986-08-06 1990-12-05 Mect Corporation Ganglioside related compounds and method of producing the same
EP0299201A3 (de) * 1987-06-12 1990-08-22 Wilhelm Dr. Hoerrmann Fett-Aminoalkohol enthaltendes Arzneimittel
ES2065343T3 (es) * 1987-06-26 1995-02-16 Solco Basel Ag Nuevos preparados farmaceuticos asi como nuevos compuestos de lactosilo y su preparacion.
US4957741A (en) * 1988-08-02 1990-09-18 Angio-Medical Corp. Method for the treatment of gastric ulcer
US5066496A (en) * 1988-08-03 1991-11-19 Angio-Medical Corporation Composition and method for treatment of gastric and duodenal ulcers and mucosal erosions
IT1235162B (it) * 1988-12-02 1992-06-22 Fidia Farmaceutici Derivati di lisosfingolipidi
DE3916072A1 (de) * 1989-05-17 1990-11-22 Thera Ges Fuer Patente Ceramidderivate und ihre verwendung als inhibitoren der sphingolipidsynthese
DE4102817A1 (de) * 1991-01-31 1992-08-06 Merck Patent Gmbh Verfahren zur stereoselektiven herstellung von (beta)-fucopyranosyl-phosphaten und sehr reiner gdp-fucose
US5936076A (en) * 1991-08-29 1999-08-10 Kirin Beer Kabushiki Kaisha αgalactosylceramide derivatives
TW261533B (es) * 1992-07-16 1995-11-01 Kirin Brewery
DE69328435T2 (de) * 1992-10-22 2000-09-14 Kirin Beer K.K., Tokio/Tokyo Neues sphingolglycolipid und verwendung davon
DE69416306T2 (de) * 1993-04-15 1999-06-17 Kirin Beer K.K., Tokio/Tokyo Sphingoglycolipid und verwendung davon
WO1995003028A1 (en) * 1993-07-23 1995-02-02 Morris Herstein Cosmetic, skin-renewal stimulating composition with long-term irritation control
US5663151A (en) * 1994-03-04 1997-09-02 Bristol-Myers Squibb Company Sulfated α-glycolipid derivatives as cell adhesion inhibitors
CA2142153A1 (en) * 1994-03-04 1995-09-05 Jacques Banville Sulfated .beta.-glycolipid derivatives as cell adhesion inhibitors
US5686426A (en) * 1994-11-17 1997-11-11 Bristol-Myers Squibb Company Dicarboxymethylated glycolipid derivatives as cell adhesion inhibitors
EP0754053A1 (en) * 1995-02-03 1997-01-22 Korea Institute of Science and Technology Novel hemostatic composition
ATE250139T1 (de) 1997-03-03 2003-10-15 Sumitomo Chemical Co Herstellung von einer optisch-aktiven sphingoid- verbindung
JP4553488B2 (ja) 1998-09-21 2010-09-29 大塚製薬株式会社 カルボキシメチルガラクトース誘導体
US20040180852A1 (en) * 2003-03-10 2004-09-16 Cara-Lynne Schengrund Use of multivalent glycodendrimers to inhibit the activity of human immunodeficiency virus
DE102004025000A1 (de) * 2004-05-21 2005-12-08 Bayer Technology Services Gmbh Verfahren zur Herstellung von chemischen und pharmazeutischen Produkten mit integrierter Mehrsäulen-Chromatographie
CN101460458A (zh) 2006-02-15 2009-06-17 阿勒根公司 具有1-磷酸-鞘氨醇(s1p)受体拮抗剂生物活性的带芳基或者杂芳基基团的吲哚-3-羧酸的酰胺、酯、硫代酰胺和硫羟酸酯化合物
WO2007112322A2 (en) * 2006-03-28 2007-10-04 Allergan, Inc. Indole compounds having sphingosine-1-phosphate (s1p) receptor agonist and/or antagonist biological activity
US7794722B2 (en) 2006-06-30 2010-09-14 The Scripps Research Institute Adjuvants and methods of use
EP2125723A1 (en) 2007-01-11 2009-12-02 Allergan, Inc. 6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (s1p) receptor antagonist biological activity
US8524917B2 (en) * 2007-01-11 2013-09-03 Allergan, Inc. 6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (S1P) receptor antagonist biological activity
CN101918360A (zh) * 2007-09-24 2010-12-15 阿勒根公司 具有1-磷酸-鞘氨醇(s1p)受体生物学活性的带芳基或者杂芳基基团的吲哚化合物
US8143291B2 (en) 2008-05-09 2012-03-27 Allergan, Inc. Indole compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (S1P) receptor biological activity
BRPI0918399A2 (pt) * 2008-08-12 2015-12-29 Allergan Inc composto antagonista do receptor de esfingosina-1-fosfato (s1p), bem como composição farmacêutica e uso do mesmo
US20120088800A1 (en) 2009-06-30 2012-04-12 Allergan, Inc. 2-(SUBSTITUTED) (ARYLMETHYL, ARYLOXY and ARYLTHIO))-N-(SUBSTITUTED PYRIDIN-2-YL)-2-(SUBSTITUTED ARYL) COMPOUNDS AS SUBTYPE-SELECTIVE MODULATORS OF SPHINGOSINE-1-PHOSPHATE-3 (S1P3) RECEPTORS
US8168795B2 (en) * 2009-08-11 2012-05-01 Allergan, Inc. Selective sphingosine-1-phosphate receptor antagonists
WO2011028927A1 (en) 2009-09-04 2011-03-10 Allergan, Inc. Selective sphingosine-1-phosphate receptor antagonists
JP2013506003A (ja) 2009-09-29 2013-02-21 アラーガン インコーポレイテッド スフィンゴシン−1−リン酸−2(s1p2)受容体のサブタイプ選択的調節因子としての縮合環ピリジン化合物
US8741875B2 (en) 2009-11-24 2014-06-03 Allergan, Inc. Compounds as receptor modulators with therapeutic utility
KR20120098796A (ko) * 2009-11-24 2012-09-05 알러간, 인코포레이티드 치료적 유용성을 지니는 수용체 조절제로서의 신규한 화합물
JP2014503501A (ja) 2010-11-22 2014-02-13 アラーガン インコーポレイテッド 治療的有用性を伴う受容体調節因子としての新規化合物
US9708354B2 (en) 2013-03-15 2017-07-18 Cerenis Therapeutics Holding Sa Methods for the synthesis of sphingomyelins and dihydrosphingomyelins
SG10201804887YA (en) 2013-03-15 2018-07-30 Cerenis Therapeutics Holding Sa Methods for the synthesis of sphingomyelins and dihydrosphingomyelins
US20240132440A1 (en) 2021-01-25 2024-04-25 Carbocode S.A. Method for the production of d-erythro-sphingosine and analogs thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1495548A (en) * 1974-04-16 1977-12-21 Tate & Lyle Ltd Sugar derivative containing vinyl groups and copolymers thereof
US4362720A (en) * 1977-04-14 1982-12-07 Chembiomed Ltd. Synthesis of 2-amino-2-deoxyglycoses and 2-amino-2-deoxyglycosides from glycals

Also Published As

Publication number Publication date
FI844775L (fi) 1985-06-06
AU3628684A (en) 1985-06-13
US4952683A (en) 1990-08-28
FI844775A0 (fi) 1984-12-04
EP0146810A2 (de) 1985-07-03
YU189686A (en) 1987-12-31
DK573384D0 (da) 1984-12-03
CA1259610A (en) 1989-09-19
DK573384A (da) 1985-06-06
AU570087B2 (en) 1988-03-03
HU195516B (en) 1988-05-30
PL250710A1 (en) 1985-07-16
YU202784A (en) 1987-02-28
ES8606373A1 (es) 1986-04-16
HUT36833A (en) 1985-10-28
NO844815L (no) 1985-06-06
PL143901B1 (en) 1988-03-31
EP0146810A3 (de) 1987-05-13
ES8604986A1 (es) 1986-03-16
ES538231A0 (es) 1986-03-16

Similar Documents

Publication Publication Date Title
ES548901A0 (es) Procedimiento para la preparacion de derivados de esfingosina
ES533260A0 (es) Procedimiento para la preparacion de 13a-alquilgonanos
ES537830A0 (es) Procedimiento para la obtencion de derivados de 5-amino-4-hidroxivalerilo sustituidos
ES544286A0 (es) Procedimiento para la preparacion de nuevos derivados tiazo-lidinicos
ES532183A0 (es) Procedimiento para la preparacion de compuestos cefemicos
ES537502A0 (es) Procedimiento para la preparacion de imidazolinonas
ES538621A0 (es) Procedimiento para la preparacion de fenolsulfonftaleinil-b-d-galactosidos
ES524997A0 (es) Procedimiento para la preparacion de derivados de la desoxiuridina
ES532572A0 (es) Procedimiento para la preparacion de n-piridilindoles
MX159669A (es) Procedimiento para la preparacion de derivados de acilamida
ES532957A0 (es) Procedimiento para la preparacion de sulfonilureas substituidas
ES538117A0 (es) Procedimiento para la preparacion de compuestos triglicidilicos de aminofenoles
ES533497A0 (es) Procedimiento para la preparacion de nuevos derivados de 3-fenil-4-cianopirrol
ES535704A0 (es) Procedimiento para la obtencion de derivados de piridinio
MX156242A (es) Procedimiento para la preparacion de eter-sulfonatos
ES535326A0 (es) Procedimiento para la preparacion de nuevos eteres tetraglioidilicos
ES535185A0 (es) Procedimiento para la preparacion de nuevas oxadiacinas
ES528114A0 (es) Procedimiento para la preparacion de hexanorbrassinolid-22-eteres
ES536969A0 (es) Procedimiento para la preparacion de nuevos derivados de 1-(acetilaminofenil)-2-amino-propanona
ES535373A0 (es) Procedimiento para la preparacion de nuevas pirazolil- e isoxazolilsulfonilureas
ES535913A0 (es) Procedimiento para la preparacion de derivados de feniletilamina
ES534338A0 (es) Procedimiento para la preparacion de derivados de acridanona
ES525034A0 (es) Procedimiento para la preparacion de derivados de 28-metil-brassinolidas
ES531024A0 (es) Procedimiento para la preparacion de aminonitrilos
MX162546A (es) Procedimiento mejorado para la preparacion de 2-halogenoresorcinoles

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970203